) of national and international Phase I-IV clinical trials in the Therapeutic Area General Medicine Act as the main point of contact to R&D Project management and Clinical Operations for assigned
) of national and international Phase I-IV clinical trials in the Therapeutic Area General Medicine Act as the main point of contact to R&D Project management and Clinical Operations for assigned
Medicinal Products (IMPs) of national and international Phase I-IV clinical trials in the Therapeutic Area General Medicine Act as the main point of contact to R&D Project management and Clinical Operations